Regadenoson 71288-0201-85

Package NDC

71288-0201-85

Manufacturer: Meitheal Pharmaceuticals Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 11, 2022
Listing Expires: December 31, 2026
Application: ANDA212806

Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Regadenoson	.08 mg/mL

Drug Class

Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]

Selected Package

71288-0201-85Selected

1 SYRINGE, PLASTIC in 1 CARTON (71288-201-85) / 5 mL in 1 SYRINGE, PLASTIC